Higher systemic levels of C-reactive protein (CRP), and soluble receptors of tumor necrosis factor-alpha (TNF-α), sTNF1 and sTNF2, accompany incident diabetes after initiation of HIV antiretroviral therapy [3]. The gene discussed is CRP; the disease is diabetes mellitus.